Estradiol cypionate

Estradiol Cypionate (ECP), also known as depo-estradiol, is a synthetic, steroidal estrogen and estrogen ester – specifically, the 3-cyclopentylpropionate ester of estradiol – which is used in hormone therapy for menopausal symptoms and in hormonal contraception. It is a long-acting form of estradiol, which is the major and most potent naturally occurring estrogen in humans. Estradiol cypionate is administered via intramuscular injection and provides a sustained release of estradiol into the bloodstream for several weeks.

Medical Uses

Estradiol cypionate is primarily used in hormone replacement therapy (HRT) for menopausal symptoms such as hot flashes, vaginal atrophy, and osteoporosis. It is also used in feminizing hormone therapy for transgender women, as part of the medical transition process. In addition, it has applications in hormonal contraception, although it is less commonly used for this purpose compared to other forms of estrogen.

Pharmacology

Mechanism of Action

Estradiol cypionate acts by binding to and activating the estrogen receptor (ER), which is found in various tissues throughout the body. This activation influences the transcription of genes that regulate the development and maintenance of female sexual characteristics, bone metabolism, and various other physiological processes.

Pharmacokinetics

Following intramuscular injection, estradiol cypionate is slowly absorbed into the bloodstream, providing a sustained release of estradiol. Its long-acting nature is due to the esterification of estradiol with cypionate, which slows its release and prolongs its action. The ester is eventually hydrolyzed, releasing active estradiol.

Adverse Effects

The adverse effects of estradiol cypionate are similar to those of other estrogen therapies and may include nausea, breast tenderness, headache, and an increased risk of thromboembolic events, such as deep vein thrombosis (DVT) and pulmonary embolism. Long-term use of estrogens has also been associated with an increased risk of endometrial cancer, which can be mitigated by the concurrent use of a progestogen in women with intact uteruses.

Contraindications

Estradiol cypionate is contraindicated in individuals with known hypersensitivity to estradiol or any component of the formulation, as well as in those with a history of estrogen-dependent tumors, active thromboembolic disease, or undiagnosed vaginal bleeding.

See Also

• Estrogen
• Hormone replacement therapy
• Transgender hormone therapy
• Estrogen ester

References

<references/>

   This article is a medical stub. You can help WikiMD by expanding it!

• 
  Estradiol 17 beta-cypionate
• 
  Estradiol cypionate molecule ball
• 
  Depo-Estradiol (estradiol cypionate) vials
• 
  Estradiol
• 
  Estradiol levels after a single subcutaneous or intramuscular injection of 5 mg estradiol cypionate
• 
  Estradiol levels at steady state with intramuscular injections of 5 mg estradiol cypionate per month in premenopausal women
• 
  Estradiol levels after a single intramuscular injection of 1.0 to 2.0 mg estradiol cypionate in hypogonadal girls
• 
  Estradiol levels after a single 5 mg intramuscular injection of estradiol esters
• 
  Idealized curves of estradiol levels after injection of different estradiol esters in women
• 
  Estradiol cypionate levels after a single intramuscular injection of 5 mg microcrystalline estradiol cypionate in aqueous suspension in women
• 
  Vaginal cornification with a single intramuscular injection of different estradiol esters in women